Lundbeck is a pharmaceutical firm headquartered in Copenhagen, laser-focused on treating brain diseases—from depression and schizophrenia to Alzheimer’s and Parkinson’s. Founded in 1915 by Hans Lundbeck, it now employs roughly 5,400 people globally and is majority-owned (about 70 %) by the Lundbeck Foundation. Their products are registered in over 100 countries—and yes, people worldwide rely on them for brain health, not because they asked for it, but because occasionally science does something useful.